Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Innovative Screening Approaches for Early Detection of MS

    Innovative Screening Approaches for Early Detection of MS supports research teams developing and validating practical tests to identify likely MS cases in risk-enriched groups and speed neurological evaluation.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Commercial Research Funding Opportunity

    The National Multiple Sclerosis Society’s Commercial Research Funding Opportunity supports innovative research to develop new MS therapies and diagnostics, bridging discovery and commercial development.

    NMSSForecasted Jan 24, 2027$800,000Forecasted

    Research Grants - National Multiple Sclerosis Society

    Research Grants support investigators pursuing fundamental and applied MS research to advance roadmap goals of stopping disease activity, restoring function, and preventing new cases of MS.

    NMSS$5,000,000Forecasted

    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

    Funding for innovative methods to screen and treat potentially fatal disorders in newborns, including genetic conditions needing screening advancements.

    HHS-NIH11Due Feb 5, 2027

    Neuroimaging and CSF Biomarkers

    Neuroimaging and CSF Biomarkers supports researchers and clinicians developing and validating biomarkers to advance drug development, diagnosis, and monitoring for Alzheimer's disease and related dementias.

    Alzheimers Drug DiscoveryDue Dec 7, 2026· 21d$600,000

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.

    HHS-NIH11Forecasted Jun 4, 2027$150,000Forecasted